These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 752309)

  • 41. Spectrum of gut immunologic reactions: selective induction of distinct responses to Vibrio cholerae WO7 and its toxin.
    Walia K; Vohra H; Singh H; Ganguly NK
    Microbiol Immunol; 2000; 44(11):931-40. PubMed ID: 11145274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proteolytic degradation of exocrine and serum immunoglobulins.
    Brown WR; Newcomb RW; Ishizaka K
    J Clin Invest; 1970 Jul; 49(7):1374-80. PubMed ID: 4194190
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A method of obtaining, processing, and analyzing human intestinal secretions for antibody content.
    Gaspari MM; Brennan PT; Solomon SM; Elson CO
    J Immunol Methods; 1988 May; 110(1):85-91. PubMed ID: 3373004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection.
    Glass RI; Svennerholm AM; Khan MR; Huda S; Huq MI; Holmgren J
    J Infect Dis; 1985 Feb; 151(2):236-42. PubMed ID: 3968450
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunological responses of rabbits to various somatic and secreted antigens of Vibrio cholerae after intra-duodenal inoculation.
    Kabir S
    J Med Microbiol; 1987 Aug; 24(1):29-40. PubMed ID: 3612742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae.
    Clements ML; Levine MM; Young CR; Black RE; Lim YL; Robins-Browne RM; Craig JP
    J Infect Dis; 1982 Apr; 145(4):465-73. PubMed ID: 7069227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vibriolytic IgG immunocyte response of mice after primary and secondary immunization with cholera somatic antigens.
    Friedman H
    Immunology; 1975 Aug; 29(2):283-99. PubMed ID: 51000
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serologic studies of naturally acquired infection with Vibrio cholerae serogroup O1 in the United States.
    Snyder JD; Allegra DT; Levine MM; Craig JP; Feeley JC; DeWitt WE; Blake PA
    J Infect Dis; 1981 Feb; 143(2):182-7. PubMed ID: 7194358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on the quantitation of immunoglobulin in human intestinal secretions.
    Samson RR; McClelland DB; Shearman DJ
    Gut; 1973 Aug; 14(8):616-26. PubMed ID: 4582728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin.
    Fontana MR; Monaci E; Yanqing L; Guoming Q; Duan G; Rappuoli R; Pizza M
    Vaccine; 2000 Aug; 19(1):75-85. PubMed ID: 10924789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A radial diffusion agar plaque technique for estimation of the avidity of bactericidal antibodies against Vibrio cholerae.
    Holmgren J; Svennerholm AM
    Scand J Immunol; 1972; 1(4):345-50. PubMed ID: 4129962
    [No Abstract]   [Full Text] [Related]  

  • 52. Preparation and properties of Vibrio cholerae antifimbrial antibody.
    Al-Kaissi E; Mostratos A
    J Appl Bacteriol; 1985 Feb; 58(2):221-9. PubMed ID: 2858464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low temperature pepsin proteolysis. An effective procedure for mouse IgM F(ab')2 fragment production.
    Pascual DW; Clem LW
    J Immunol Methods; 1992 Feb; 146(2):249-55. PubMed ID: 1538146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibodies to the truncated (short) form of 'O' polysaccharides (TFOP) of Vibrio cholerae O139 lipopolysaccharides protect mice against experimental cholera induced by encapsulated O139 strains and such protection is mediated by inhibition of intestinal colonization of vibrios.
    Nandy RK; Mukhopadhyay S; Ghosh AN; Ghose AC
    Vaccine; 1999 Jul; 17(22):2844-52. PubMed ID: 10438055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
    García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
    Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Local production of anti-vibrio cholerae mucosal antibody in reproductive tract tissues after cholera.
    Ryan ET; Bridges EA; Crean TI; Gausia K; Hamadani JD; Aziz A; Hawkes S; Begum M; Bogaerts J; Faruque SM; Salam MA; Fuchs GJ; Calderwood SB
    J Infect Dis; 2001 Sep; 184(5):643-7. PubMed ID: 11494170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study of intestinal immunity against V. cholerae: role of antibody to V. cholerae haemagglutinin in intestinal immunity.
    Chaicumpa W; Atthasisiha N
    Southeast Asian J Trop Med Public Health; 1977 Mar; 8(1):13-8. PubMed ID: 887992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum or breast milk immunoglobulins mask the self-reactivity of human natural IgG antibodies.
    Djoumerska-Alexieva I; Manoylov I; Dimitrov JD; Tchorbanov A
    APMIS; 2014 Apr; 122(4):329-40. PubMed ID: 23937153
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide.
    Levinson KJ; Giffen SR; Pauly MH; Kim DH; Bohorov O; Bohorova N; Whaley KJ; Zeitlin L; Mantis NJ
    J Immunol Methods; 2015 Jul; 422():111-7. PubMed ID: 25865265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.